US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
TMS Co Ltd
TSE:4891
TMS Co Ltd
Cash from Financing Activities
TMS Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
TMS Co Ltd
TSE:4891
|
Cash from Financing Activities
ÂĄ688.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
GNI Group Ltd
TSE:2160
|
Cash from Financing Activities
ÂĄ10.7B
|
CAGR 3-Years
90%
|
CAGR 5-Years
53%
|
CAGR 10-Years
11%
|
|
PeptiDream Inc
TSE:4587
|
Cash from Financing Activities
ÂĄ647.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
115%
|
CAGR 10-Years
-18%
|
|
Takara Bio Inc
TSE:4974
|
Cash from Financing Activities
-ÂĄ5.2B
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Cash from Financing Activities
ÂĄ2.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
155%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Financing Activities
-ÂĄ134k
|
CAGR 3-Years
53%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
See Also
What is TMS Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
688.1m
JPY
Based on the financial report for Feb 29, 2024, TMS Co Ltd's Cash from Financing Activities amounts to 688.1m JPY.
What is TMS Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-15%
Over the last year, the Cash from Financing Activities growth was -59%. The average annual Cash from Financing Activities growth rates for TMS Co Ltd have been -15% over the past three years .